This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Absorption rate

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Plasma concentration versus time: o= rapid absorption ³ o x= normal absorption ³ o o += slow release Toxic ÃÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄ ³ o xo Conc. ³ x x ³ o o x Therap'ticÃÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄ ³ x o + x + ³ o + x + ³ x + o x + ³ + x ³o x+ o ÀÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄÄ Time

In absorption, the plasma concentration reaches a peak and then falls away to nothing. The curve depends on the rate and extent of absorption. Thus, in rapid absorption the peak may be very high, such that this plasma concentration may be toxic. In some instances, such as GTN in angina, the side effects from very rapid absorption are acceptable. In slow absorption the rate of release may be sufficiently slow that a detectable plasma concentration is never reached. Importantly though, the total area under curve is the same - i.e. the extent of absorption is the same.

Disease may alter the profile - e.g. analgesics in migraine - such that therapeutic concentration is not reached. In this instance other drugs, such as metaclopramide, may be used to increase gastric opening, and thus promote the absorption of aspirin or paracetamol.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.